Detalhe da pesquisa
1.
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Lancet
; 401(10374): 347-356, 2023 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739136
2.
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
PLoS One
; 17(6): e0268534, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35675343
3.
Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
Clin Pharmacol Ther
; 106(4): 866-873, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31038729
4.
Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project.
J Am Med Inform Assoc
; 25(7): 893-898, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29444243
5.
Isoniazid-induced polyneuropathy in a tuberculosis patient - implication for individual risk stratification with genotyping?
Brain Behav
; 5(8): e00326, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26355945
6.
One non-believer: Response to "Obviously Nine Believers: Actionable Germline Genetic Variants for Pre-emptive Pharmacogenetic Testing".
Basic Clin Pharmacol Toxicol
; 126(1): 7-8, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31670867
7.
No association of common VCP variants with sporadic frontotemporal dementia.
Neurobiol Aging
; 30(2): 333-5, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17618707
8.
Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures.
Neurobiol Aging
; 28(5): 727-34, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16675064
9.
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
Hum Mol Genet
; 15(16): 2446-56, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16825285